All eyes on data on Biogen’s tau therapy
Biogen's experimental anti-tau therapy shows promise in slowing cognitive decline for early Alzheimer's patients.
Velocity timeline
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
Biogen has presented Phase 2 CELIA data at the AAIC, demonstrating that its anti-tau oligonucleotide, diranersen, achieved robust tau reduction and meaningful clinical outcomes. According to STAT, the drug slowed cognitive decline at rates comparable to currently approved therapies.
Coverage from Fierce Biotech, STAT, and AP News emphasizes the drug's potential as researchers seek new approaches to treat Alzheimer's. Biogen reports that these results bolster hopes for the therapy's upcoming pivotal push.
Future attention remains on the progress of this experimental drug as it moves toward further clinical development.
Synthesized by Newsylist from the headlines below under a strict no-invention contract. ✓ fact-checked: all claims supported by sources Updated just now.
Quick answers
What is the name of the drug being tested?
The anti-tau oligonucleotide is called diranersen.
Where were the results presented?
The Phase 2 CELIA data was presented at the AAIC.
How did the drug perform compared to other therapies?
According to STAT, the study shows the drug slowed decline at rates on par with approved therapies.
Coverage (5)
- AAIC: Biogen bolsters hopes for Alzheimer's pivotal push as anti-tau oligo slows cognitive decline Fierce Biotech · 1d ago
- Biogen Presents Phase 2 CELIA Data at AAIC Demonstrating Meaningful Clinical Outcomes and Robust Tau Reduction with Diranersen in Early Alzheimer’s Disease Biogen · 1d ago
- Biogen Alzheimer's drug slowed decline at rates on par with approved therapies, study shows STAT · 1d ago broke it first
- An experimental Alzheimer's drug shows some promise as researchers hunt new approaches AP News · 1d ago
- All eyes on data on Biogen’s tau therapy STAT · 1d ago broke it first
People, places & organizations
Topics
Related trends
The 2 brain-healthy habits a neurologist swears by
Medical experts are highlighting preventable risk factors and specific daily habits to reduce the likelihood of dementia and cognitive decline.
A Drug Already Proven Safe in Humans Just Reduced Multiple Signs of Alzheimer's in Mice
The drug candidate KCL-286 has shown potential in preclinical mouse studies to reduce multiple signs of Alzheimer's disease.
Scientists Discover a Sign of Dementia up to 15 Years Before Diagnosis
Scientists have identified indicators of dementia, including work performance shifts and blood biomarkers, that may appear up to 15 years before diagnosis.
Alcohol Alters Brain Flexibility Based on Hidden Dementia Markings
Alcohol consumption alters brain flexibility based on hidden dementia markings
Danny Glover, 79, reveals heartbreaking Alzheimer’s diagnosis: ‘Things are going to be different’
Actor Danny Glover, 79, has publicly announced his diagnosis of Alzheimer's disease.
Scientists may have finally found how Alzheimer's spreads through the brain
Researchers have identified the Arc protein as a key driver in the spread of toxic tau within the brain during Alzheimer's progression.